These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38386952)

  • 21. Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
    Dissak-Delon FN; Kamga GR; Humblet PC; Robert A; Souopgui J; Kamgno J; Essi MJ; Ghogomu SM; Godin I
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005849. PubMed ID: 28806785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
    Efon-Ekangouo A; Nana-Djeunga HC; Nzune-Toche N; Dongmo-Yemele R; Bopda J; Ongbassomben V; Sumo L; Geiger A; Nutman TB; Kamgno J
    PLoS Negl Trop Dis; 2023 Apr; 17(4):e0011250. PubMed ID: 37058547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
    Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of epilepsy in Ndom Health District (Littoral Region, Cameroon) after long-term ivermectin-based preventive chemotherapy for the control of onchocerciasis.
    Efon-Ekangouo A; Nana-Djeunga HC; Nwane P; Lisongue-Tonga E; Domche A; Sumo L; Osei-Atweneboana MY; Geiger A; Kamgno J
    Epilepsy Behav; 2022 Nov; 136():108939. PubMed ID: 36252289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report.
    Donfo-Azafack C; Nana-Djeunga HC; Wafeu-Sadeu G; Dongmo-Yemele R; Kamgno J
    J Med Case Rep; 2023 Apr; 17(1):141. PubMed ID: 37062821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin.
    Siewe Fodjo JN; Tatah G; Tabah EN; Ngarka L; Nfor LN; Chokote SE; Mengnjo MK; Dema F; Sitouok AT; Nkoro G; Ntone FE; Bissek AZ; Chesnais CB; Boussinesq M; Colebunders R; Njamnshi AK
    Infect Dis Poverty; 2018 Dec; 7(1):114. PubMed ID: 30501640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon.
    Forrer A; Wanji S; Obie ED; Nji TM; Hamill L; Ozano K; Piotrowski H; Dean L; Njouendou AJ; Ekanya R; Ndongmo WPC; Fung EG; Nnamdi DB; Abong RA; Beng AA; Eyong ME; Ndzeshang BL; Nkimbeng DA; Teghen S; Suireng A; Ashu EE; Kah E; Murdoch MM; Thomson R; Theobald S; Enyong P; Turner JD; Taylor MJ
    BMJ Glob Health; 2021 Jan; 6(1):. PubMed ID: 33431378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis.
    Twum-Danso NA; Meredith SE
    Trop Med Int Health; 2003 Sep; 8(9):820-31. PubMed ID: 12950668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
    Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
    Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
    Kouam MK; Tchatchueng-Mbougua JB; Demanou M; Boussinesq M; Pion SD; Kamgno J
    Parasit Vectors; 2013 Sep; 6(1):283. PubMed ID: 24289520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of epilepsy and relationship with onchocerciasis prevalence in villages of the Ntui Health District of Cameroon.
    Ngarka L; Siewe Fodjo JN; Ambomatei C; Njamnshi WY; Taryunyu Njamnshi JN; Nfor LN; Mengnjo MK; Njamnshi AK
    Epilepsy Behav; 2023 May; 142():109184. PubMed ID: 36972641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Parasitological efficacy of repeated treatments with ivermectin in an onchocerciasis focus in north Cameroon].
    Boussinesq M; Chippaux JP; Ernould JC; Prod'Hon J; Quillévéré D
    Bull Soc Pathol Exot; 1993; 86(2):112-5. PubMed ID: 8353468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria.
    Brieger WR; Okeibunor JC; Abiose AO; Wanji S; Elhassan E; Ndyomugyenyi R; Amazigo UV
    Parasit Vectors; 2011 Jul; 4():152. PubMed ID: 21794139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon.
    Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
    Parasit Vectors; 2018 Jun; 11(1):356. PubMed ID: 29921312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivermectin distribution and the cultural context of forest onchocerciasis in South Province, Cameroon.
    Hewlett BS; Kollo B; Cline BL
    Am J Trop Med Hyg; 1996 May; 54(5):517-22. PubMed ID: 8644908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reach and Utility of COVID-19 Information and Preventive Measures for Nomadic Populations in Massangam, West Region of Cameroon.
    Atekem K; Dixon R; Nditanchou R; Makia CM; Ntsinda M; Basnet S; Schmidt E
    Am J Trop Med Hyg; 2022 Mar; 106(5):1491-7. PubMed ID: 35235908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Important progress towards elimination of onchocerciasis in the West Region of Cameroon.
    Kamga GR; Dissak-Delon FN; Nana-Djeunga HC; Biholong BD; Ghogomu SM; Souopgui J; Kamgno J; Robert A
    Parasit Vectors; 2017 Aug; 10(1):373. PubMed ID: 28774318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
    Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.